21129 Search Results


atcc 21129  (ATCC)
92
ATCC atcc 21129
Atcc 21129, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atcc 21129/product/ATCC
Average 92 stars, based on 1 article reviews
atcc 21129 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
kiaa1199  (Proteintech)
93
Proteintech kiaa1199
<t>KIAA1199</t> was upregulated in the liver fibrosis mouse model. (a) Representative H&E, Masson and Sirius Red staining (100×) of the CCl 4 -induced liver fibrosis mouse model. (b) Immunohistochemistry (100×) for α-SMA and KIAA1199 in the liver fibrosis mouse model. (c) The mRNA levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. (d) Representative image showing the protein levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01.
Kiaa1199, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kiaa1199/product/Proteintech
Average 93 stars, based on 1 article reviews
kiaa1199 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
open reading frame unigene identifier mm.21129  (Unigene)
90
Unigene open reading frame unigene identifier mm.21129
<t>KIAA1199</t> was upregulated in the liver fibrosis mouse model. (a) Representative H&E, Masson and Sirius Red staining (100×) of the CCl 4 -induced liver fibrosis mouse model. (b) Immunohistochemistry (100×) for α-SMA and KIAA1199 in the liver fibrosis mouse model. (c) The mRNA levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. (d) Representative image showing the protein levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01.
Open Reading Frame Unigene Identifier Mm.21129, supplied by Unigene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/open reading frame unigene identifier mm.21129/product/Unigene
Average 90 stars, based on 1 article reviews
open reading frame unigene identifier mm.21129 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
amnh 21129-32 (males)  (Ceram GmbH)
90
Ceram GmbH amnh 21129-32 (males)
<t>KIAA1199</t> was upregulated in the liver fibrosis mouse model. (a) Representative H&E, Masson and Sirius Red staining (100×) of the CCl 4 -induced liver fibrosis mouse model. (b) Immunohistochemistry (100×) for α-SMA and KIAA1199 in the liver fibrosis mouse model. (c) The mRNA levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. (d) Representative image showing the protein levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01.
Amnh 21129 32 (Males), supplied by Ceram GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amnh 21129-32 (males)/product/Ceram GmbH
Average 90 stars, based on 1 article reviews
amnh 21129-32 (males) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


KIAA1199 was upregulated in the liver fibrosis mouse model. (a) Representative H&E, Masson and Sirius Red staining (100×) of the CCl 4 -induced liver fibrosis mouse model. (b) Immunohistochemistry (100×) for α-SMA and KIAA1199 in the liver fibrosis mouse model. (c) The mRNA levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. (d) Representative image showing the protein levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01.

Journal: Open Medicine

Article Title: Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition

doi: 10.1515/med-2023-0689

Figure Lengend Snippet: KIAA1199 was upregulated in the liver fibrosis mouse model. (a) Representative H&E, Masson and Sirius Red staining (100×) of the CCl 4 -induced liver fibrosis mouse model. (b) Immunohistochemistry (100×) for α-SMA and KIAA1199 in the liver fibrosis mouse model. (c) The mRNA levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. (d) Representative image showing the protein levels of α-SMA and KIAA1199 in the liver fibrosis mouse model. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01.

Article Snippet: The primary antibodies used were as follows: α-SMA (1:10,000, ab124964; Abcam), KIAA1199 (1:1,000, 21129-1-AP; Proteintech), COL1A1 (1:1,000, 67288-1-Ig; Proteintech), cyclin B1 (1:1,000, 12231; CST), cyclinD1 (1:1,000, 2978; CST), Bax (1:1,000, 5023; CST), Bcl-2 (1:1,000, 4223; CST), E-cadherin (1:1,000, 20874-1-AP; Proteintech), N-cadherin (1:1,000, 22018-1-AP; Proteintech), claudin-1 (1:1,000, A2196; Abclonal), Snai1 (1:1,000, 13099-1-AP; Proteintech), vimentin (1:1,000, 10366-1-AP; Proteintech), MMP2 (1:1,000, 4022; CST), MMP9 (1:1,000, 3852; CST), and β-actin (1:5,000, 66009-1-AP; Proteintech).

Techniques: Staining, Immunohistochemistry, Control, Standard Deviation

KIAA1199 was involved in the activation of HSCs. (a) The mRNA levels of α-SMA, COL1A1, and KIAA1199 in LX-2 cells after TGF-β stimulation. (b) The protein levels of α-SMA, COL1A1, and KIAA1199 in LX-2 cells after TGF-β stimulation. (c) RT-qPCR and (d) western blot analysis of α-SMA, COL1A1, and KIAA1199 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199), pretreated with or without TGF-β. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Journal: Open Medicine

Article Title: Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition

doi: 10.1515/med-2023-0689

Figure Lengend Snippet: KIAA1199 was involved in the activation of HSCs. (a) The mRNA levels of α-SMA, COL1A1, and KIAA1199 in LX-2 cells after TGF-β stimulation. (b) The protein levels of α-SMA, COL1A1, and KIAA1199 in LX-2 cells after TGF-β stimulation. (c) RT-qPCR and (d) western blot analysis of α-SMA, COL1A1, and KIAA1199 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199), pretreated with or without TGF-β. β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Article Snippet: The primary antibodies used were as follows: α-SMA (1:10,000, ab124964; Abcam), KIAA1199 (1:1,000, 21129-1-AP; Proteintech), COL1A1 (1:1,000, 67288-1-Ig; Proteintech), cyclin B1 (1:1,000, 12231; CST), cyclinD1 (1:1,000, 2978; CST), Bax (1:1,000, 5023; CST), Bcl-2 (1:1,000, 4223; CST), E-cadherin (1:1,000, 20874-1-AP; Proteintech), N-cadherin (1:1,000, 22018-1-AP; Proteintech), claudin-1 (1:1,000, A2196; Abclonal), Snai1 (1:1,000, 13099-1-AP; Proteintech), vimentin (1:1,000, 10366-1-AP; Proteintech), MMP2 (1:1,000, 4022; CST), MMP9 (1:1,000, 3852; CST), and β-actin (1:5,000, 66009-1-AP; Proteintech).

Techniques: Activation Assay, Quantitative RT-PCR, Western Blot, Expressing, Transfection, Control, Standard Deviation

KIAA1199 knockdown inhibits proliferation and promotes apoptosis of HSCs. (a) The proliferation rates of LX-2 cells transfected with siRNAs (si NC or si KIAA1199) were determined by the CCK-8 assay. (b) RT-qPCR and (c) western blot analysis of cyclin B1(CCNB1) and cyclin D1(CCND1) expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (d) Flow cytometry shows the apoptosis of LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (e) RT-qPCR and (f) western blot analysis of Bax and Bcl-2 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Journal: Open Medicine

Article Title: Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition

doi: 10.1515/med-2023-0689

Figure Lengend Snippet: KIAA1199 knockdown inhibits proliferation and promotes apoptosis of HSCs. (a) The proliferation rates of LX-2 cells transfected with siRNAs (si NC or si KIAA1199) were determined by the CCK-8 assay. (b) RT-qPCR and (c) western blot analysis of cyclin B1(CCNB1) and cyclin D1(CCND1) expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (d) Flow cytometry shows the apoptosis of LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (e) RT-qPCR and (f) western blot analysis of Bax and Bcl-2 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Article Snippet: The primary antibodies used were as follows: α-SMA (1:10,000, ab124964; Abcam), KIAA1199 (1:1,000, 21129-1-AP; Proteintech), COL1A1 (1:1,000, 67288-1-Ig; Proteintech), cyclin B1 (1:1,000, 12231; CST), cyclinD1 (1:1,000, 2978; CST), Bax (1:1,000, 5023; CST), Bcl-2 (1:1,000, 4223; CST), E-cadherin (1:1,000, 20874-1-AP; Proteintech), N-cadherin (1:1,000, 22018-1-AP; Proteintech), claudin-1 (1:1,000, A2196; Abclonal), Snai1 (1:1,000, 13099-1-AP; Proteintech), vimentin (1:1,000, 10366-1-AP; Proteintech), MMP2 (1:1,000, 4022; CST), MMP9 (1:1,000, 3852; CST), and β-actin (1:5,000, 66009-1-AP; Proteintech).

Techniques: Knockdown, Transfection, CCK-8 Assay, Quantitative RT-PCR, Western Blot, Expressing, Flow Cytometry, Control, Standard Deviation

KIAA1199 knockdown inhibited HSC migration and suppressed EMT. (a) Cell migration in LX-2 cells (100×) was analyzed using the Transwell assay. (b) RT-qPCR and (c) western blot analysis of MMP-2 and MMP-9 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (d) RT-qPCR and (e) western blot analysis of E-cadherin, Claudin-1, N-cadherin, Snail1, and vimentin expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Journal: Open Medicine

Article Title: Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition

doi: 10.1515/med-2023-0689

Figure Lengend Snippet: KIAA1199 knockdown inhibited HSC migration and suppressed EMT. (a) Cell migration in LX-2 cells (100×) was analyzed using the Transwell assay. (b) RT-qPCR and (c) western blot analysis of MMP-2 and MMP-9 expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). (d) RT-qPCR and (e) western blot analysis of E-cadherin, Claudin-1, N-cadherin, Snail1, and vimentin expression in LX-2 cells transfected with siRNAs (si NC or si KIAA1199). β-Actin was used as a loading control. Each bar represents mean ± standard deviation of three separate experiments. ** P < 0.01 and *** P < 0.001.

Article Snippet: The primary antibodies used were as follows: α-SMA (1:10,000, ab124964; Abcam), KIAA1199 (1:1,000, 21129-1-AP; Proteintech), COL1A1 (1:1,000, 67288-1-Ig; Proteintech), cyclin B1 (1:1,000, 12231; CST), cyclinD1 (1:1,000, 2978; CST), Bax (1:1,000, 5023; CST), Bcl-2 (1:1,000, 4223; CST), E-cadherin (1:1,000, 20874-1-AP; Proteintech), N-cadherin (1:1,000, 22018-1-AP; Proteintech), claudin-1 (1:1,000, A2196; Abclonal), Snai1 (1:1,000, 13099-1-AP; Proteintech), vimentin (1:1,000, 10366-1-AP; Proteintech), MMP2 (1:1,000, 4022; CST), MMP9 (1:1,000, 3852; CST), and β-actin (1:5,000, 66009-1-AP; Proteintech).

Techniques: Knockdown, Migration, Transwell Assay, Quantitative RT-PCR, Western Blot, Expressing, Transfection, Control, Standard Deviation